Literature DB >> 9868642

Infection due to Yersinia enterocolitica in a series of patients with beta-thalassemia: incidence and predisposing factors.

T V Adamkiewicz1, M Berkovitch, C Krishnan, C Polsinelli, D Kermack, N F Olivieri.   

Abstract

Over 15 years, 14 patients with yersiniosis in two North American comprehensive thalassemia clinics (0.6 cases per 100 patient-years) presented with fever (100%), diarrhea (86%), right-lower-quadrant abdominal pain (71%), bacteremia (57%), a palpable abdominal mass (36%), and pharyngitis (28%). Clinically apparent infection occurred within 10 days of blood transfusion in 57% of patients. Nine patients (64%) had only a modest elevation in serum level of ferritin (< 2,000 micrograms/L). Patients with focal abdominal findings had a higher body iron burden, as estimated by the serum ferritin level, and significant intraabdominal suppurative complications. Two patients were not receiving iron-chelating therapy with deferoxamine; one patient was receiving the experimental chelator deferiprone (L1). Iron-loaded patients with beta-thalassemia are at greatly increased risk for severe yersiniosis, even when their body iron burden (as indicated by the serum ferritin level) is only moderately elevated and they are not receiving iron-chelating therapy with deferoxamine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9868642     DOI: 10.1086/515025

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

1.  The descriptive epidemiology of yersiniosis: a multistate study, 2005-2011.

Authors:  Apurba Chakraborty; Kenneth Komatsu; Matthew Roberts; Jim Collins; Jennifer Beggs; George Turabelidze; Tom Safranek; Jean-Marie Maillard; Linda J Bell; David Young; Nicola Marsden-Haug; Rachel F Klos; Mark S Dworkin
Journal:  Public Health Rep       Date:  2015 May-Jun       Impact factor: 2.792

Review 2.  Salmonella, Shigella, and yersinia.

Authors:  John P Dekker; Karen M Frank
Journal:  Clin Lab Med       Date:  2015-04-02       Impact factor: 1.935

3.  Comparison of the effects of deferiprone versus deferoxamine on growth and virulence of Yersinia enterocolitica.

Authors:  Biliana Lesic; Jeannine Foulon; Elisabeth Carniel
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 4.  An emergency diagnostic dilemma: a case of Yersinia enterocolitica colitis mimicking acute appendicitis in a beta-thalassemia major patient: the role of CT and literature review.

Authors:  Petros Antonopoulos; Fotois Constantinidis; Georgios Charalampopoulos; Konstantinos Dalamarinis; Ioannis Karanicas; Garyfallia Kokkini
Journal:  Emerg Radiol       Date:  2007-07-10

5.  Management of transfusional iron overload - differential properties and efficacy of iron chelating agents.

Authors:  Janet L Kwiatkowski
Journal:  J Blood Med       Date:  2011-09-21

Review 6.  Primary cellulitis and cutaneous abscess caused by Yersinia enterocolitica in an immunocompetent host: A case report and literature review.

Authors:  Hirofumi Kato; Shugo Sasaki; Noritaka Sekiya
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

Review 7.  Use of the clinical microbiology laboratory for the diagnosis and management of infectious diseases related to the oral cavity.

Authors:  L R Peterson; R B Thomson
Journal:  Infect Dis Clin North Am       Date:  1999-12       Impact factor: 5.982

8.  Treating thalassemia major-related iron overload: the role of deferiprone.

Authors:  Vasilios Berdoukas; Kallistheni Farmaki; Susan Carson; John Wood; Thomas Coates
Journal:  J Blood Med       Date:  2012-10-19

Review 9.  Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic Diseases.

Authors:  Giuseppe Leone; Eligio Pizzigallo
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-10-13       Impact factor: 2.576

Review 10.  Acute appendicitis-advances and controversies.

Authors:  Thomas Zheng Jie Teng; Xuan Rong Thong; Kai Yuan Lau; Sunder Balasubramaniam; Vishal G Shelat
Journal:  World J Gastrointest Surg       Date:  2021-11-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.